Revenue + Forward P/E
Zimmer Biomet Holdings, Inc. (ZBH) quarterly revenue and forward P/EForward P/E: 11.2x
RevenueRevenue (est)Forward P/E
Fair value & valuation models
Fair value models are a Plus feature
Upgrade to Plus for the interactive DCF model, valuation bands, and implied-price scenarios.
71% OFF$23.99 $6.99/mo
Ends in23:59:59
Cancel anytime. Secure checkout via Stripe.
Valuation
Market cap
$19.00B
Enterprise value
$24.20B
P/E ratio (TTM)
22.91x
P/S ratio (TTM)
2.04x
P/B ratio
1.36x
EV/Sales
2.88x
EV/EBITDA
10.97x
Dividend yield
1.08%
Income statement (TTM)
Revenue (TTM)
$8.23B
Gross profit (TTM)
$5.07B
Operating income (TTM)
$1.36B
EBITDA (TTM)
$2.22B
Net income (TTM)
$705.20M
Free cash flow (TTM)
$1.47B
Margins & returns
Gross margin
70.03%
Operating margin
15.61%
Profit margin
9.05%
Return on equity
6.01%
Return on assets
3.35%
Per-share metrics
EPS (TTM)
$3.90
Dividend yield
1.08%
Beta
0.46
Capital structure
Cash & equivalents
$591.90M
Total debt
$7.52B
Net debt
$6.93B
Shares outstanding
193.46M
Financial health
Current ratio
1.98
Debt / equity
0.59
Debt / assets
0.33
Interest coverage
4.65
| Company | Market cap | P/E | P/S | EV/EBITDA | Div yield |
|---|---|---|---|---|---|
| $1.15T | 42.41x | 15.59x | 34.80x | 0.54% | |
| $630.37B | 30.45x | 6.47x | 20.76x | 1.99% | |
| $442.95B | 127.13x | 7.29x | 30.82x | 2.63% | |
| $364.62B | 27.06x | 0.85x | 16.46x | 2.13% | |
| $354.73B | 23.91x | 4.80x | 15.14x | 2.67% | |
| $332.71B | 36.82x | 4.94x | 19.57x | 2.56% | |
| $19.00B | 22.91x | 2.04x | 10.97x | 1.08% |